Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
US WorldMeds
US WorldMeds
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Corgard
Nadolol
1982-01-01
Heart failure
,
Hypertension
,
Myocardial infarction
,
Angina pectoris
,
Nephrotic syndrome
,
Edema
Lucemyra
Lofexidine
2018-05-16
Substance withdrawal syndrome
Melphalan
Melphalan
2019-05-03
2029-2036
Myeloid leukemia acute
,
Breast neoplasms
,
Ovarian neoplasms
,
Non-hodgkin lymphoma
,
Multiple myeloma
,
Neuroblastoma
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Hematopoietic stem cell transplantation
,
Hodgkin disease
,
Rhabdomyosarcoma
Revonto
Dantrolene
2007-07-24
2025
Multiple sclerosis
,
Spinal cord injuries
,
Cerebral infarction
,
Muscle spasticity
,
Cerebral palsy
,
Malignant hyperthermia
,
Neuroleptic malignant syndrome
Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use